The Klinique Medical Clinic PCL (BKK:KLINIQ)

BKK:KLINIQ Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	533.26	247.91	108.48	464.44	75.91	9.28
Short-Term Investments	406.05	530.63	1,060	1,000	-	-
Cash & Short-Term Investments	939.31	778.54	1,168	1,464	75.91	9.28
Cash Growth	-14.90%	-33.37%	-20.21%	1829.24%	717.54%	-73.72%
Accounts Receivable	12.81	7.32	12.44	2.88	1.47	0.88
Other Receivables	-	0.04	-	-	-	-
Receivables	12.81	7.36	12.44	2.88	1.47	0.88
Inventory	319.71	271.63	191.09	120.05	84.24	103.1
Prepaid Expenses	28.32	29.46	25.34	17.95	5.57	19.35
Other Current Assets	61.42	57.21	79.93	72.24	35.26	58.89
Total Current Assets	1,362	1,144	1,477	1,678	202.44	191.5
Property, Plant & Equipment	1,753	1,795	1,216	818.35	534.11	510.65
Long-Term Investments	-	-	0.1	-	-	-
Other Intangible Assets	4.15	4.51	3.7	3.65	2.31	0.8
Long-Term Deferred Tax Assets	10.27	10.92	6.61	3.14	-	11.11
Other Long-Term Assets	173.97	163.62	142.29	87.55	75.44	58.03
Total Assets	3,303	3,118	2,846	2,590	814.3	772.09
Accounts Payable	199.42	117.36	88.79	62.87	32.78	15.81
Accrued Expenses	77.21	86.29	85.32	71.81	53.1	48.43
Short-Term Debt	-	-	-	-	-	12.94
Current Portion of Leases	127.5	127.72	90.45	70.82	58.1	50.3
Current Income Taxes Payable	59.88	39.17	30.55	20.9	20.43	20.2
Current Unearned Revenue	435.92	405.76	400.82	403.31	288.76	301.62
Other Current Liabilities	60.2	88.69	70.04	75.69	45.75	43.23
Total Current Liabilities	960.12	864.98	765.97	705.4	498.92	492.53
Long-Term Leases	514.37	530.33	371.01	234.29	148.89	149.1
Long-Term Deferred Tax Liabilities	0.32	-	-	-	1.37	14.28
Other Long-Term Liabilities	3.34	3.34	3.34	3.36	3.38	3.93
Total Liabilities	1,481	1,401	1,143	944.5	653.79	660.85
Common Stock	110	110	110	110	80	80
Additional Paid-In Capital	1,415	1,415	1,415	1,415	12.29	12.29
Retained Earnings	287.83	203.03	188.92	131.85	79.49	30.23
Comprehensive Income & Other	-11.27	-11.27	-11.27	-11.27	-11.27	-11.27
Total Common Equity	1,802	1,717	1,703	1,646	160.5	111.25
Minority Interest	20.02	0	-	-	-	-
Shareholders' Equity	1,822	1,717	1,703	1,646	160.5	111.25
Total Liabilities & Equity	3,303	3,118	2,846	2,590	814.3	772.09
Total Debt	641.87	658.04	461.46	305.1	206.99	212.34
Net Cash (Debt)	297.44	120.5	707.02	1,159	-131.08	-203.06
Net Cash Growth	-48.06%	-82.96%	-39.02%	-	-	-
Net Cash Per Share	1.35	0.55	3.21	6.83	-0.82	-1.27
Filing Date Shares Outstanding	220	220	220	220	160	160
Total Common Shares Outstanding	220	220	220	220	160	160
Working Capital	401.45	279.22	711.32	972.16	-296.48	-301.03
Book Value Per Share	8.19	7.80	7.74	7.48	1.00	0.70
Tangible Book Value	1,798	1,712	1,699	1,642	158.2	110.45
Tangible Book Value Per Share	8.17	7.78	7.72	7.46	0.99	0.69
Buildings	-	322.49	240.73	184.81	128.06	110.83
Machinery	-	1,387	989.11	711.57	514.16	488.8
Construction In Progress	-	9.17	17.43	11.2	13.29	0.71

Source: S&P Global Market Intelligence. Standard template. Financial Sources.